REQUEST A DEMO
Total
USD $0.00
Search more companies

Vivunt Pharma Colombia Sas (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Vivunt Pharma Colombia Sas Profile Updated: May 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Vivunt Pharma Colombia Sas is an enterprise in Colombia, with the main office in Bogota D.C.. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on June 25, 2020. Vivunt Pharma Colombia Sas currently employs 1 (2024) people. There was a net sales revenue increase of 210.13% reported in Vivunt Pharma Colombia Sas’s latest financial highlights for 2023. A growth of 54.18% was recorded in its total assets. The net profit margin of Vivunt Pharma Colombia Sas increased by 155.33% in 2023.

Headquarters
Cr 12 # 89 33 P 6
Bogota D.C.; Bogota D.C; Postal Code: 0807

Contact Details: Purchase the Vivunt Pharma Colombia Sas report to view the information.

Basic Information
Total Employees:
Purchase the Vivunt Pharma Colombia Sas report to view the information.
Outstanding Shares:
Purchase the Vivunt Pharma Colombia Sas report to view the information.
Incorporation Date:
June 25, 2020
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Company Performance
Financial values in the chart are available after Vivunt Pharma Colombia Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
210.13%
Total operating revenue
210.13%
Operating profit (EBIT)
86.06%
Net Profit (Loss) for the Period
91.23%
Total assets
54.18%
Total equity
10.55%
Operating Profit Margin (ROS)
96.03%
Net Profit Margin
155.33%
Return on Equity (ROE)
-100.32%
Quick Ratio
0.9%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?